These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7485543)

  • 1. DARPP-32 promoter directs transgene expression to renal thick ascending limb of loop of Henle.
    Blau S; Daly L; Fienberg A; Teitelman G; Ehrlich ME
    Am J Physiol; 1995 Oct; 269(4 Pt 2):F564-70. PubMed ID: 7485543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of electrolyte transport in the kidney through a dopamine- and cAMP-regulated phosphoprotein, DARPP-32.
    Fryckstedt J; Meister B; Aperia A
    J Auton Pharmacol; 1992 Jun; 12(3):183-9. PubMed ID: 1321155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine- and cAMP-regulated phosphoprotein (DARPP-32) and dopamine DA1 agonist-sensitive Na+,K+-ATPase in renal tubule cells.
    Meister B; Fryckstedt J; Schalling M; Cortés R; Hökfelt T; Aperia A; Hemmings HC; Nairn AC; Ehrlich M; Greengard P
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8068-72. PubMed ID: 2573060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of L-amino acid decarboxylase and DARPP-32 in the kidney.
    Aperia A; Hökfelt T; Meister B; Bertorello A; Fryckstedt J; Holtbäck U; Seri I
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):11S-13S. PubMed ID: 2166532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated Mr 32,000 dopamine- and cAMP-regulated phosphoprotein inhibits Na+,K(+)-ATPase activity in renal tubule cells.
    Aperia A; Fryckstedt J; Svensson L; Hemmings HC; Nairn AC; Greengard P
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2798-801. PubMed ID: 1849276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine and protein phosphatase activity in renal proximal tubules.
    Slobodyansky E; Aoki Y; Gaznabi AK; Aviles DH; Fildes RD; Jose PA
    Am J Physiol; 1995 Feb; 268(2 Pt 2):F279-84. PubMed ID: 7864167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DARPP-32 genomic fragments drive Cre expression in postnatal striatum.
    Bogush AI; McCarthy LE; Tian C; Olm V; Gieringer T; Ivkovic S; Ehrlich ME
    Genesis; 2005 May; 42(1):37-46. PubMed ID: 15830379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning of cDNA for DARPP-32, a dopamine- and cyclic AMP-regulated neuronal phosphoprotein.
    Kurihara T; Lewis RM; Eisler J; Greengard P
    J Neurosci; 1988 Feb; 8(2):508-17. PubMed ID: 3339428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32.
    Flores-Hernández J; Cepeda C; Hernández-Echeagaray E; Calvert CR; Jokel ES; Fienberg AA; Greengard P; Levine MS
    J Neurophysiol; 2002 Dec; 88(6):3010-20. PubMed ID: 12466426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein phosphatase-1 in the kidney: evidence for a role in the regulation of medullary Na(+)-K(+)-ATPase.
    Li D; Aperia A; Celsi G; da Cruz e Silva EF; Greengard P; Meister B
    Am J Physiol; 1995 Nov; 269(5 Pt 2):F673-80. PubMed ID: 7503233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of dopamine- and cAMP-dependent phosphoprotein (DARPP-32) in the developing and mature kidney.
    Fryckstedt J; Aperia A; Snyder G; Meister B
    Kidney Int; 1993 Sep; 44(3):495-502. PubMed ID: 8231021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D(1) dopamine receptor activation reduces GABA(A) receptor currents in neostriatal neurons through a PKA/DARPP-32/PP1 signaling cascade.
    Flores-Hernandez J; Hernandez S; Snyder GL; Yan Z; Fienberg AA; Moss SJ; Greengard P; Surmeier DJ
    J Neurophysiol; 2000 May; 83(5):2996-3004. PubMed ID: 10805695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium-dependent regulation of sodium, potassium-adenosine-tri-phosphatase (Na+, K(+)-ATPase) activity in medullary thick ascending limb of Henle segments. Effect of cyclic-adenosine-monophosphate guanosine-nucleotide-binding-protein activity and arginine vasopressin.
    Fryckstedt J; Aperia A
    Acta Physiol Scand; 1992 Feb; 144(2):185-90. PubMed ID: 1315476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat DARPP-32: cloning, sequencing, and characterization of the cDNA.
    Ehrlich ME; Kurihara T; Greengard P
    J Mol Neurosci; 1990; 2(1):1-10. PubMed ID: 1979497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the 32-kilodalton dopamine and cyclic adenosine 3',5'-monophosphate-regulated phosphoprotein in common adenocarcinomas.
    Beckler A; Moskaluk CA; Zaika A; Hampton GM; Powell SM; Frierson HF; El-Rifai W
    Cancer; 2003 Oct; 98(7):1547-51. PubMed ID: 14508844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RARbeta isoform-specific regulation of DARPP-32 gene expression: an ectopic expression study in the developing rat telencephalon.
    Liao WL; Liu FC
    Eur J Neurosci; 2005 Jun; 21(12):3262-8. PubMed ID: 16026464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated neuronal phosphoprotein. I. Amino acid sequence around the phosphorylated threonine.
    Hemmings HC; Williams KR; Konigsberg WH; Greengard P
    J Biol Chem; 1984 Dec; 259(23):14486-90. PubMed ID: 6501302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine modulation of membrane excitability in striatal spiny neurons is altered in DARPP-32 knockout mice.
    Onn SP; Fienberg AA; Grace AA
    J Pharmacol Exp Ther; 2003 Sep; 306(3):870-9. PubMed ID: 12805477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DARPP-32 and modulation of cAMP signaling: involvement in motor control and levodopa-induced dyskinesia.
    Håkansson K; Lindskog M; Pozzi L; Usiello A; Fisone G
    Parkinsonism Relat Disord; 2004 Jul; 10(5):281-6. PubMed ID: 15196506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of DARPP-32 in the actions of drugs of abuse.
    Nairn AC; Svenningsson P; Nishi A; Fisone G; Girault JA; Greengard P
    Neuropharmacology; 2004; 47 Suppl 1():14-23. PubMed ID: 15464122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.